LENEXA, Kan., Jan. 23, 2006 (PRIMEZONE) -- Mediware Information Systems (Nasdaq:MEDW) today announces that New York City's Hospital for Special Surgery is the latest hospital to select Mediware's next generation HCLL(tm) Transfusion Software to assist in securing the delivery of high-quality patient care in a safe environment.
A member of the NewYork-Presbyterian Healthcare System, Hospital for Special Surgery (HSS) is world-renowned for musculoskeletal medicine and has received five-star ratings for clinical excellence in joint replacements, orthopedic care, and spine surgery.
In addition to serving as a safety control system of HSS' Blood Bank and Musculoskeletal Tissue Bank, the Mediware system will simplify and enhance procedures performed by laboratory technologists. It is a partnership that also affords future growth in the ever-evolving healthcare industry.
"HSS has been a customer of Mediware's for over 20 years, and in 2004 we began looking for a one-vendor solution to accommodate our complex software needs," said Stephanie Lovece, Assistant Vice President, Laboratory Medicine. "In the HCLL(tm) transfusion product, we found both the flexibility and ease-of-use we needed to improve the daily workflow of the lab, and still satisfy all regulatory and patient safety requirements."
"The look and feel of the application is just right, with the most critical information available at a single glance," noted Kethel Allen, Blood and Tissue Bank Chief Technologist and Tissue Bank Compliance Officer at HSS. "The ease with which we will be able to retrieve historical data further supports our decision to use HCLL(tm) Transfusion."
"Supporting clinical best practices is paramount to a healthcare IT organization. We proudly serve as a technology partner with HSS and we are committed to the delivery of advanced technology which helps caregivers to safeguard and improve health outcomes," stated James Burgess, CEO of Mediware Information Systems.
About HSS
Founded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked as No. 2 in orthopedics, No. 3 in rheumatology and as among the best in geriatrics and neurology by U.S. News & World Report, and received Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center. In the 2006 edition of HealthGrades' Hospital Quality in America Study, HSS received five-star ratings for clinical excellence in its specialties. A member of the NewYork-Presbyterian Healthcare System and an affiliate of Weill Medical College of Cornell University, HSS provides orthopedic and rheumatologic patient care at NewYork-Presbyterian Hospital at NewYork Weill Cornell Medical Center. All HSS medical staff is on the faculty of Weill Medical College of Cornell University. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City, www.hss.edu.
About Mediware
Mediware is a leading provider of software solutions and services for medication management, blood and cellular products and perioperative departments. With over 1,100 worldwide installations, Mediware provides hospitals, clinics, correctional institutions, blood centers and other, public and private, health care institutions with proprietary software solutions for blood donor testing and distribution, transfusion services, tissue management, cord blood processing and stem cell management, pharmacy, medication management, ordering and electronic prescribing, medication administration support beyond checking the "5 rights," patient safety alerts, clinical content, operating room scheduling, preference management, and surgical case documentation. Mediware provides a full suite of support and related services for each of its solutions. For more information about Mediware, its services and products, including HCLL(tm) Transfusion and Donor, LifeTrak(r), WORx(r), MediMAR(r), MediCOE(tm), Perioperative Solutions(tm), and JAC medicine management systems visit www.Mediware.com.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2005, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.